Studies involving sample source:T-cells
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST000140 | Cell Rinsing Solution Comparison | Human | University of Florida |
| ST000144 | Primary T Cell Baseline (Donor 5) - II | Human | University of Michigan |
| ST000145 | Primary T Cell Noxa Knockdown (Donor 8) | Human | University of Michigan |
| ST000146 | Noxa regulation of malate aspartate shuttle | Human | University of Michigan |
| ST000147 | 13C targeted metabolomics | Human | University of Michigan |
| ST000153 | Primary T Cell Noxa Knockdown (Donor 8)-II | Human | University of Michigan |
| ST000154 | Use of Aspartate Dehydrogenase by cancer cells | Human | University of Michigan |
| ST000178 | T cell metabolism during graft-versus-host disease (CAB 307)-PART I | Mouse | University of Michigan |
| ST000181 | T cell metabolism during graft-versus-host disease(CAB 311) | Mouse | University of Michigan |
| ST000370 | Primary T Cell Noxa Knockdown (Donor 8) III | Human | University of Michigan |
| ST000949 | Human NK vs T cell metabolism using 13C-Glucose tracer (part I) | Human | University of Kentucky |
| ST000950 | Human NK vs T cell metabolism using 13C-Glucose tracer with/out galactose (part II) | Human | University of Kentucky |
| ST000951 | Human NK vs T cell metabolism using 13C-Glucose tracer with/out oligomycin (part III) | Human | University of Kentucky |
| ST000952 | Human NK vs T cell metabolism using 13C-Glucose tracer with/out oligomycin and galactose (part IV) | Human | University of Kentucky |
| ST001476 | Design of Experiments for Maximizing T cell endpoints | Human | University of Georgia |
| ST001675 | Quantitative measurements of ceramides and glycosphingolipids in Th17 and iTreg cells (part-II) | Human | University of Turku |
| ST001676 | Lipidomic analysis of CD4+ T-cell subsets (Th1,Th2,Th17 and iTreg cells) (part I) | Human | University of Turku |
| ST001677 | Quantitative targeted measurements of sphingolipids in Th17 cells before and after the triple knockdown of SPTLC1,2,3 genes (SPT, de novo pathway: sphingolipid metabolism) (part-III) | Human | University of Turku |
| ST001678 | Quantitative measurements of sphingolipids in Th17 cells before and after the knockdown of UGCG gene (GCS pathway: sphingolipid metabolism) (part-IV) | Human | University of Turku |
| ST001679 | Quantitative measurements of sphingomyelins in Th17 cells before and after the knockdown of UGCG gene (GCS pathway: sphingolipid metabolism) (part-V) | Human | University of Turku |
| ST001986 | Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells | Mouse | University of Cambridge |
| ST002071 | Metabolic profiling of mouse CD27+ and CD27- gammadelta T cells | Mouse | University of Louisville |
| ST002185 | Lipidomic characterization of Jurkat-derived T cell line in which the chaperonin complex CCT has been partially silenced | Human | Centro Nacional de Investigaciones Cardiovasculares Carlos III |
| ST002486 | Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis - mouse blood T-cell metabolomics | Mouse | University of Colorado Denver |
| ST002487 | Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis - mouse spleen and lymph node T-cell metabolomics | Mouse | University of Colorado Denver |
| ST002488 | Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis - T-cell tracing supernatants | Mouse | University of Colorado Denver |
| ST002489 | Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis | Mouse | University of Colorado Denver |
| ST003091 | T cell Immune Escape in Blast Crisis Transformation of Chronic Myeloid Leukemia | Mouse | Translational Genomics Research Institute |
| ST003166 | Metabolomics of Murine WT or MCJ KO CD19-BBz CD8 CAR-T cells | Mouse | University of Colorado School of Medicine |
| ST003167 | Metabolomics of Human CD19-BBz CD8 CAR-T cells with low and high MCJ expression | Human | University of Colorado School of Medicine |
| ST003169 | Metabolomics of infused Murine WT or MCJ KO CD19-BBz CD8 CAR-T cells from Leukemia-bearing Mice | Mouse | University of Colorado School of Medicine |
| ST003170 | Metabolomics of Murine WT or MCJ KO CD19-BBz CD8 CAR-T cells rest in medium | Mouse | University of Colorado School of Medicine |
| ST003265 | Malic Enzyme 2 maintains metabolic state and anti-tumor immunity of CD8+ T cells | Mouse | Peking Union Medical College |
| ST003626 | Metabolomic profile of human regulatory T cells. | Human | Jikei University School of Medicine |
| ST003627 | Lipidomic analysis of human regulatory T cells. | Human | Jikei University School of Medicine |
| ST003629 | Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells | Human | Leibniz Institute for Plasma Science and Technology |
| ST003664 | Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function. | Mouse | University of Chicago |
| ST003779 | Overcoming resistance to immunotherapy by targeting CD38 in human tumor explants - Intracellular metabolomics of B7.H3 human CAR-T cells | Human | Massachusetts General Hospital |
| ST003914 | G1P promotes pentose phosphate pathway in CD8+ memory T cells via glycogen-G6PD phase separation and compartmentalization | Mouse | Peking Union Medical College |
| ST003963 | Immunometabolic determinants of long-term response in preinfusion CAR-T cells of the leukemia patients receiving CD19 CAR T cell therapy | Human | Translational Genomics Research Institute |
| ST003964 | Immunometabolism determinants of enhanced antileukemic activity upon rapamycin mediated mTOR inhibition in CAR-T cells of short-term responder leukemia patients receiving CD19 CAR T cell therapy | Human | Translational Genomics Research Institute |
| ST003965 | Immunometabolic determinants of long-term response in leukapheresis T cells of the leukemia patients receiving CD19 CAR T cell therapy | Human | Translational Genomics Research Institute |
| ST003966 | Immunometabolic determinants of long-term response in bone marrow of the leukemia patients receiving CD19 CAR T cell therapy | Human | Translational Genomics Research Institute |
| ST004093 | Autoimmune Disease Risk Gene ANKRD55 Promotes T Cell Proliferation and Th17 2 Effector Function Through Metabolic Modulation | Mouse | Broad Institute of MIT and Harvard |
| ST004215 | Intra-tumoral hypoxia promotes CD8+ T cell dysfunction via chronic activation of integrated stress response transcription factor ATF4 | Mouse | University of North Carolina at Chapel Hill |
| ST004242 | Glycolysis inhibition functionally reprograms T follicular helper cells and reverses lupus - lupus prone W.Yaa mouse treated with 2-deoxy-D-glucose | Mouse | UT Health San Antonio |
| ST004243 | Glycolysis inhibition functionally reprograms T follicular helper cells and reverses lupus - human Lupus patients | Human | UT Health San Antonio |
| ST004333 | Oxidative pentose phosphate pathway is required for T cell activation and anti-tumor immunity - G6PD-knockout | Mouse | Princeton University |
| ST004334 | Oxidative pentose phosphate pathway is required for T cell activation and anti-tumor immunity - PGD-knockout | Mouse | Princeton University |
